Literature DB >> 15969930

Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin.

Yi Wang1, Jiang Cao, Su Zeng.   

Abstract

Quercetin, kaempferol, and isorhamnetin were the most important flavonoid constituents in extracts from Ginkgo biloba leaves. Transport studies of Ginkgo flavonols were performed in Caco-2 cell mono-layers. Their apparent permeability in absorptive and secretion directions was determined, and quercetin, kaempferol and isorhamnetin displayed polarized transport, with the Papp,B-A being higher than the Papp,A-B (P<0.01 for quercetin, P<0.001 for kaempferol and isorhamnetin, Student's t-test). Bcap37/MDR1 cells, which were transfected with a P-glycoprotein (P-gp) gene construct, were treated with quercetin, kaempferol or isorhamnetin. The concentrations of Ginkgo flavonol in Bcap37/MDR1 cells were lower than those in parent cells (P<0.05 for quercetin, P<0.01 for isorhamnetin, Mann-Whitney U test). The concentrations of the flavonol in transfected cells increased when incubated with the P-gp inhibitor verapamil (P<0.05 for kaempferol, Mann-WhitneyU test). A colorometric assay for ATPase activity was applied to the detection of interaction of flavonol with P-gp. Quercetin and kaempferol inhibited the ATPase activity, and isorhamnetin stimulated the ATPase activity (P<0.05 for isorhamnetin, Mann Whitney U test). The results indicated that Ginkgo flavonols quercetin, kaempferol and isorhamnetin were substrates of P-gp. The P-gp type efflux pump might limit the bioavailability of Ginkgo flavonols.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969930     DOI: 10.1211/0022357056299

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  19 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

Review 2.  Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Authors:  Enoche F Oga; Shuichi Sekine; Yoshihisa Shitara; Toshiharu Horie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-04       Impact factor: 2.441

3.  In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.

Authors:  Liang Zheng; Lijun Zhu; Min Zhao; Jian Shi; Yuhuan Li; Jia Yu; Huangyu Jiang; Jinjun Wu; Yunli Tong; Yuting Liu; Ming Hu; Linlin Lu; Zhongqiu Liu
Journal:  AAPS J       Date:  2016-07-08       Impact factor: 4.009

Review 4.  Interindividual differences in phytochemical metabolism and disposition.

Authors:  Johanna W Lampe; Jyh-Lurn Chang
Journal:  Semin Cancer Biol       Date:  2007-05-13       Impact factor: 15.707

Review 5.  Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.

Authors:  Lilian W Kibathi; SoHyun Bae; Scott R Penzak; Parag Kumar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

6.  A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration.

Authors:  Jingze Duan; Yang Dang; Houjun Meng; Huizhen Wang; Ping Ma; Guowen Li; Tao Wu; Yan Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-23       Impact factor: 2.441

Review 7.  Interindividual differences in response to plant-based diets: implications for cancer risk.

Authors:  Johanna W Lampe
Journal:  Am J Clin Nutr       Date:  2009-03-18       Impact factor: 7.045

8.  Food dyes as P-glycoprotein modulators.

Authors:  Jack W Staples; Jessica M Stine; Eero Mäki-Lohiluoma; Emily Steed; Kathleen M George; Charles M Thompson; Erica L Woodahl
Journal:  Food Chem Toxicol       Date:  2020-10-01       Impact factor: 6.023

9.  Effects of some common food constituents on cardiovascular disease.

Authors:  Yaling Yang; Sze Wa Chan; Miao Hu; Richard Walden; Brian Tomlinson
Journal:  ISRN Cardiol       Date:  2011-06-16

10.  The steady-state serum concentration of genistein aglycone is affected by formulation: a bioequivalence study of bone products.

Authors:  Alessandra Bitto; Bruce P Burnett; Francesca Polito; Silvia Russo; Rosario D'Anna; Lakshmi Pillai; Francesco Squadrito; Domenica Altavilla; Robert M Levy
Journal:  Biomed Res Int       Date:  2012-12-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.